Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,732,636
+$11,905,187 QoQ
Shares Held
720,648
+33.9% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Derivatives in BEAM
reported options exposure · as of Jun 30, 2021CallValue
$1,531,649
CallShares
11,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. BEAM ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in BEAM
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,732,636 | 720,648 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,827,449 | 538,290 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $11,845,528 | 427,328 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,906,909 | 779,024 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $14,481,223 | 851,336 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,158,921 | 673,780 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,395,937 | 136,933 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,229,681 | 539,987 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,484,868 | 362,137 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,607,555 | 321,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,289,605 | 194,328 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,819,540 | 366,717 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,692,669 | 178,286 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,562,722 | 377,620 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,418,651 | 164,118 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,706,078 | 119,775 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,352,043 | 138,260 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,890,951 | 137,713 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,707,167 | 109,263 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,515,887 | 17,422 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,973,766 | 15,335 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $1,531,649 | 11,900 | Call | Defined | 2021-09-13 | |
| 2021-03-31 | $1,595,996 | 19,940 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $743,086 | 9,102 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $111,084 | 4,512 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $242,928 | 8,676 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $117,396 | 6,522 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||